Exact Mass: 303.1352

Exact Mass Matches: 303.1352

Found 172 metabolites which its exact mass value is equals to given mass value 303.1352, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Evodiamine

(1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE

C19H17N3O (303.1372)


Evodiamine is a member of beta-carbolines. Evodiamine is a natural product found in Vepris soyauxii, Cryptocarya, and other organisms with data available. Origin: Plant; Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Formula(Parent): C19H17N3O; Bottle Name:Evodiamine; Origin: Plant; PRIME Parent Name:Evodiamine; PRIME in-house No.:V0296; SubCategory_DNP: Monoterpenoid indole alkaloids, Indoloquinolizidine alkaloids, Indole alkaloids Annotation level-1 (±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1]. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor. Evodiamine is an alkaloid isolated from the fruit of Evodia rutaecarpa Bentham with diverse biological activities including anti-inflammatory, anti-obesity, and antitumor.

   

Nicotianamine

(S,S,S)-nicotianamine

C12H21N3O6 (303.143)


The (S,S,S)-stereoisomer of nicotianamine. IPB_RECORD: 2921; CONFIDENCE confident structure

   

Phenoxybenzamine

Wellspring brand OF phenoxybenzamine hydrochloride

C18H22ClNO (303.139)


Phenoxybenzamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. [PubChem]Phenoxybenzamine produces its therapeutic actions by blocking alpha receptors, leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Retigabine

Ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

Chlorphenoxamine

Chlorphenoxamine

C18H22ClNO (303.139)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

Pipemidic acid

5,8-Dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)pyrido(2,3-D)pyrimidine-6-carboxylic acid

C14H17N5O3 (303.1331)


Pipemidic acid is a member of the pyridopyrimidine class of antibacterials, which display some overlap in mechanism of action with analogous pyridone-containing quinolones. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

2-Amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-C-hydroxycarbonimidoyl)butanoate

C12H21N3O6 (303.143)


N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses. N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is a constituent of the seeds of green gram (Vigna radiata). Constituent of the seeds of green gram (Vigna radiata). N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine is found in pulses.

   

Chlorphenoxamine

{2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl}dimethylamine

C18H22ClNO (303.139)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chlorphenoxamine is a first-generation ethanolamine H1-antihistamine. Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. Target: Histamine Receptor

   

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

3-[(4-carboxy-2-hydroxy-3-methylbut-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H21NO7 (303.1318)


(2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-4-hydroxy-3-methylpent-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (2E)-4-hydroxy-3-methylpent-2-enedioylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-ethylglutarylCoA lyase deficiency (PMID: 32685354). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate

(1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulphonic acid

C12H21N3O4S (303.1253)


   

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine

C18H22ClNO (303.139)


   

Evodiamine

21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

C19H17N3O (303.1372)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   

NOTA

2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid

C12H21N3O6 (303.143)


   

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

4-[(5-amino-3,4-dihydro-2H-pyrrole-2-carbonyl)amino]-N-(3,3-diaminoprop-2-enylidene)-1H-pyrrole-2-carboxamide

C13H17N7O2 (303.1444)


   
   
   

Maybridge2_000618

Maybridge2_000618

C16H21N3OS (303.1405)


   

Mycosporine glutamicol

Mycosporine glutamicol

C13H21NO7 (303.1318)


   

Methyl 2,3-di-O-acetyl-4-(acetylamino)-4,6-dideoxyhexopyranoside #

Methyl 2,3-di-O-acetyl-4-(acetylamino)-4,6-dideoxyhexopyranoside #

C13H21NO7 (303.1318)


   
   
   

Me glycoside,N-Ac,2,4-di-O Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

Me glycoside,N-Ac,2,4-di-O Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

C13H21NO7 (303.1318)


   

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

(13bS)-8,13,13b,14-tetrahydro-1-methylindolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one|Latifoliamide D

C19H17N3O (303.1372)


   
   

SCHEMBL20542530

SCHEMBL20542530

C12H21N3O6 (303.143)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

SCHEMBL7241324

SCHEMBL7241324

C12H21N3O6 (303.143)


   
   

(±)-Evodiamine

(+/-)-Evodiamine

C19H17N3O (303.1372)


(±)-Evodiamine, a quinazolinocarboline alkaloid, is a Top1 inhibitor. Evodiamine exhibits anti-inflammatory, antiobesity, and antitumor effects. (±)-Evodiamine inhibits the proliferation of a wide variety of tumor cells by inducing their apoptosis[1].

   
   

Pipemidic acid

Pipemidic acid

C14H17N5O3 (303.1331)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3075

   

phenoxybenzamine

phenoxybenzamine

C18H22ClNO (303.139)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents KEIO_ID P206; [MS2] KO009176 KEIO_ID P206

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Acarbose (component 1)

Acarbose (component 1)

C13H21NO7 (303.1318)


   

N5-Acetyl-N2-g-glutamylornithine, 9ci

2-amino-4-[(1-carboxy-4-acetamidobutyl)carbamoyl]butanoic acid

C12H21N3O6 (303.143)


   

ethyltris(2-hydroxyethyl)ammonium ethyl sulphate

ethyltris(2-hydroxyethyl)ammonium ethyl sulphate

C10H25NO7S (303.1352)


   

2-Acetamido-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

2-Acetamido-2-deoxy-4,6-O-isopropylidene-D-glucopyranose

C13H21NO7 (303.1318)


   

2-Methoxy-3-(trifluoromethyl)pyridine-5-boronic acid pinacol ester

2-Methoxy-3-(trifluoromethyl)pyridine-5-boronic acid pinacol ester

C13H17BF3NO3 (303.1254)


   

Uracil,6-amino-5-(2-anilinoacetamido)-1,3-dimethyl- (5CI)

Uracil,6-amino-5-(2-anilinoacetamido)-1,3-dimethyl- (5CI)

C14H17N5O3 (303.1331)


   

4-tert-butyl-N-(4-methylphenyl)benzenesulfonamide

4-tert-butyl-N-(4-methylphenyl)benzenesulfonamide

C17H21NO2S (303.1293)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(4-fluorophenyl)-1-piperazinyl]

C16H18FN3O2 (303.1383)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(2-fluorophenyl)-1-piperazinyl]-

C16H18FN3O2 (303.1383)


   

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

tert-butyl 2-(aminomethyl)-3-[4-(trifluoromethyl)phenyl]propanoate

C15H20F3NO2 (303.1446)


   

1H-Indole-1-carboxylic acid, 5-acetyl-2-borono-, 1-(1,1-dimethylethyl) ester (9CI)

1H-Indole-1-carboxylic acid, 5-acetyl-2-borono-, 1-(1,1-dimethylethyl) ester (9CI)

C15H18BNO5 (303.1278)


   

Metadin

Pipradrol hydrochloride

C18H22ClNO (303.139)


   

Pipemidic acid trihydrate

Pipemidic acid trihydrate

C14H17N5O3 (303.1331)


   

2-[5-[morpholin-4-yl(phenyl)methyl]tetrazol-1-yl]acetic acid

2-[5-[morpholin-4-yl(phenyl)methyl]tetrazol-1-yl]acetic acid

C14H17N5O3 (303.1331)


   

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4H-pyran

C19H17N3O (303.1372)


   

ETHYL 2-(2-[4-(TERT-BUTYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

ETHYL 2-(2-[4-(TERT-BUTYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

C17H21NO2S (303.1293)


   

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)aniline

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethoxy)aniline

C13H17BF3NO3 (303.1254)


   

Diphenylpiperidin-4-ylmethanol hydrochloride

Diphenylpiperidin-4-ylmethanol hydrochloride

C18H22ClNO (303.139)


   

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)aniline

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)aniline

C13H17BF3NO3 (303.1254)


   

2,5-Diethoxy-4-((4-methylphenyl)thio)aniline

2,5-Diethoxy-4-((4-methylphenyl)thio)aniline

C17H21NO2S (303.1293)


   

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C13H17BF3NO3 (303.1254)


   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRIMIDIN-2-AMINE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRIMIDIN-2-AMINE

C12H17BF3N3O2 (303.1366)


   

N,N-Diphenyl-4-methoxybenzamide

N,N-Diphenyl-4-methoxybenzamide

C20H17NO2 (303.1259)


   

2-(2,2,2-Trifluoroethoxy)pyridine-3-boronic acid pinacol ester

2-(2,2,2-Trifluoroethoxy)pyridine-3-boronic acid pinacol ester

C13H17BF3NO3 (303.1254)


   

4-Diphenylmethoxypiperidine hydrochloride

4-Diphenylmethoxypiperidine hydrochloride

C18H22ClNO (303.139)


   

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

(S)-2-Amino-5-(((S)-1-((carboxymethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid

C12H21N3O6 (303.143)


   

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

C16H21N3OS (303.1405)


   
   

SH-Tripeptide-4

SH-Tripeptide-4

C12H21N3O6 (303.143)


   

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine

C12H21N3O6 (303.143)


   

Retigabine

Retigabine

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators

   

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

(2S)-1-[(3S)-3-{[(3S)-3-ammonio-3-carboxylatopropyl]ammonio}-3-carboxylatopropyl]azetidinium-2-carboxylate

C12H21N3O6 (303.143)


   

D-nopalinate(1-)

D-nopalinate(1-)

C11H19N4O6- (303.1305)


Conjugate base of D-nopaline in which the three carboxy groups are anionic and the secondary amino and guanidino groups are cationic; major species at pH 7.3.

   

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

(2E)-4-Hydroxy-3-methylpent-2-enedioylcarnitine

C13H21NO7 (303.1318)


   

N-hydroxy-7-(naphthalen-2-ylthio)heptanamide

N-hydroxy-7-(naphthalen-2-ylthio)heptanamide

C17H21NO2S (303.1293)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

7-methyl-7,8-dihydro-6H-dichromeno[3,2-c:2,3-d]pyridine

7-methyl-7,8-dihydro-6H-dichromeno[3,2-c:2,3-d]pyridine

C20H17NO2 (303.1259)


   

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

1-[[(1-Methyl-2-benzimidazolyl)amino]methyl]-2-naphthalenol

C19H17N3O (303.1372)


   

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

2-[2-(Ethylthio)-1-benzimidazolyl]-1-(1-piperidinyl)ethanone

C16H21N3OS (303.1405)


   

1-(1-Adamantyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone

1-(1-Adamantyl)-2-[(1-oxido-2-pyridin-1-iumyl)thio]ethanone

C17H21NO2S (303.1293)


   

Leu-Asp-Gly

Leu-Asp-Gly

C12H21N3O6 (303.143)


A tripeptide composed of L-leucine, L-aspartic acid and glycine joined in sequence by peptide linkages.

   
   
   

Glutamyl-valyl-glycine

Glutamyl-valyl-glycine

C12H21N3O6 (303.143)


   

4,6-Dimethyl-3-(3-naphthalen-1-yl-acryloyl)-1H-pyridin-2-one

4,6-Dimethyl-3-(3-naphthalen-1-yl-acryloyl)-1H-pyridin-2-one

C20H17NO2 (303.1259)


   

N-[(3,5-dimethoxyphenyl)methyl]-1-[4-(methylthio)phenyl]methanamine

N-[(3,5-dimethoxyphenyl)methyl]-1-[4-(methylthio)phenyl]methanamine

C17H21NO2S (303.1293)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

6,8,10-Trimethylbenzo[4,5]cyclohepta[1,2-b]indole-9,11-diol

6,8,10-Trimethylbenzo[4,5]cyclohepta[1,2-b]indole-9,11-diol

C20H17NO2 (303.1259)


   

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

N-[(Z)-1H-indol-3-ylmethylideneamino]-2-phenylcyclopropane-1-carboxamide

C19H17N3O (303.1372)


   

(R,R,R)-nicotianamine

(R,R,R)-nicotianamine

C12H21N3O6 (303.143)


   

(S,R,R)-nicotianamine

(S,R,R)-nicotianamine

C12H21N3O6 (303.143)


   

(R,S,S)-nicotianamine

(R,S,S)-nicotianamine

C12H21N3O6 (303.143)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

(7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1444)


   

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctanoate

C14H23O7- (303.1444)


   

D-23129

N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester

C16H18FN3O2 (303.1383)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics D049990 - Membrane Transport Modulators Same as: D09569

   

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

N-(N-(3-Amino-3-carboxypropyl)-3-amino-3-carboxypropyl)azetidine-2-carboxylic acid

C12H21N3O6 (303.143)


   

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

N5-Acetyl-N2-gamma-L-glutamyl-L-ornithine

C12H21N3O6 (303.143)


   

(S,S,S)-nicotianamine trizwitterion

(S,S,S)-nicotianamine trizwitterion

C12H21N3O6 (303.143)


An amino acid zwitterion resulting from transfer of three protons from the carboxy to the amino groups of (S,S,S)-nicotianamine. One of two major microspecies at physiological pH.

   
   
   

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

2-methyl-10-{[(1e)-2-phenylethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O (303.1372)


   

(1r)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

(1r)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one

C19H17N3O (303.1372)


   

2-amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-c-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-carboxy-4-[(1-hydroxyethylidene)amino]butyl}-c-hydroxycarbonimidoyl)butanoic acid

C12H21N3O6 (303.143)


   

5-hydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

5-hydroxy-4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C13H21NO7 (303.1318)


   

2-amino-4-{[3-(2-carboxyazetidin-1-yl)propyl]amino}pentanedioic acid

2-amino-4-{[3-(2-carboxyazetidin-1-yl)propyl]amino}pentanedioic acid

C12H21N3O6 (303.143)


   

(2s,4s)-2-amino-4-({3-[(2r)-2-carboxyazetidin-1-yl]propyl}amino)pentanedioic acid

(2s,4s)-2-amino-4-({3-[(2r)-2-carboxyazetidin-1-yl]propyl}amino)pentanedioic acid

C12H21N3O6 (303.143)


   

n-(5-{[(1e)-2-carbamimidoyleth-1-en-1-yl]carbamoyl}-1h-pyrrol-3-yl)-5-iminopyrrolidine-2-carboximidic acid

n-(5-{[(1e)-2-carbamimidoyleth-1-en-1-yl]carbamoyl}-1h-pyrrol-3-yl)-5-iminopyrrolidine-2-carboximidic acid

C13H17N7O2 (303.1444)


   

n-{5-[(3,3-diaminoprop-2-en-1-ylidene)carbamoyl]-1h-pyrrol-3-yl}-5-iminopyrrolidine-2-carboximidic acid

n-{5-[(3,3-diaminoprop-2-en-1-ylidene)carbamoyl]-1h-pyrrol-3-yl}-5-iminopyrrolidine-2-carboximidic acid

C13H17N7O2 (303.1444)


   

2-methyl-10-[(2-phenylethenyl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

2-methyl-10-[(2-phenylethenyl)amino]-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one

C19H17N3O (303.1372)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-[(1-hydroxyethylidene)amino]pentanoic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-5-[(1-hydroxyethylidene)amino]pentanoic acid

C12H21N3O6 (303.143)


   

(4s)-5-hydroxy-4-{[(5s)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

(4s)-5-hydroxy-4-{[(5s)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanoic acid

C13H21NO7 (303.1318)